[The portal hypertension syndrome. Limitations of medical treatment and prevention of complications].
The aetiopathogenesis of portal hypertension and the hepatic and renal haemodynamics involved in the syndrome are reviewed. Medical treatment possibilities are then considered in the light of the mechanisms underlying the condition. Modalities of diuretic treatment and the possibilities of controlling it in order to prevent the onset of a hepato-renal syndrome are discussed, particular attention being paid to the role of volaemia.
D000959:Antihypertensive Agents / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D014665:Vasodilator Agents / Q000627:therapeutic use
D000959:Antihypertensive Agents; D004232:Diuretics; D005938:Glucocorticoids; D014665:Vasodilator Agents; D004298:Dopamine
La sindrome da ipertensione portale. Limiti del trattamento medico e prevenzione delle complicanze.